| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 8 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $636.65M | - | |
| CEO | 296.8K | $7.27M | - | |
| Other | 282.8K | $6.93M | - | |
| Other | 216.6K | $5.30M | - | |
| Dir | 38.2K | $935.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | Watts Ryan J.77 | President And CEO | Sell | 18,334 | $18.09 | $331,664.30 | -0.3% | |
| Oct 1, 2018 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $21.72 | $398,192.76 | -0.7% | |
| Oct 1, 2018 | Ho Carole73 | Chief Medical Officer | Sell | 17,500 | $21.72 | $380,100.00 | -8.7% | |
| Sep 4, 2018 | Ho Carole73 | Chief Medical Officer | Sell | 17,500 | $19.05 | $333,375.00 | -8.0% | |
| Sep 4, 2018 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $19.06 | $349,426.98 | -0.7% | |
| Aug 29, 2018 | Ho Carole73 | Chief Medical Officer | Sell | 17,500 | $18.04 | $315,700.00 | -7.4% | |
| Aug 29, 2018 | Watts Ryan J.77 | President And CEO | Sell | 18,334 | $18.05 | $330,928.70 | -0.7% | |
| Dec 12, 2017 | Bratton Douglas K | 10% Owner | Buy | 275,000 | $18.00 | $4,950,000.00 | +1.4% |